PPT-2 Vol 1, CKD, Ch 1 vol
Author : liane-varnes | Published Date : 2018-11-09
1 Table 11 Distribution of NHANES participants with diabetes selfreported cardiovascular disease amp single sample markers of CKD 20072012 Data Source National Health
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "2 Vol 1, CKD, Ch 1 vol" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
2 Vol 1, CKD, Ch 1 vol: Transcript
1 Table 11 Distribution of NHANES participants with diabetes selfreported cardiovascular disease amp single sample markers of CKD 20072012 Data Source National Health and Nutrition Examination Survey NHANES 19881994 19992004 amp 20052012 participants age 20 amp older Note Cardiovascular disease designation is based on selfreport of any CVD condition see CKD Analytical Methods chapter for detail CKD is defined as eGFR lt60 or ACR 30 Abbreviations ACR urine albumincreatinine ratio CKD chronic kidney disease SR CVD selfreported cardiovascular disease DM diabetes mellitus eGFR estimated glomerular filtration rate not applicable. Pro: Andy Stein. Con: Dan Ford. Chair: Prof. Higgins. Tuesday, 5. th. November 2013, 1-2pm. CSB Room 00067. The expanding definition of CKD is unnecessarily labelling many people as diseased: Summary. Josh Exley. Learning Objectives. Acute Kidney Injury. Drugs and the Kidney. Chronic Kidney Disease. Normal Kidney function. Kidney Functions. Excretory function. Filter metabolites, toxins, drugs. Homeostatic function. Metformin must be considered the cornerstone of treatment when not contraindicated (eGFR <30). In patients not at goal on metformin monotherapy, adding an SGLT. 2. inhibitor like empagliflozin is warranted when not contraindicated (eGFR <45). ( ) CVD benefit ?Class effect?. Program Goals. Hepcidin in Chronic Kidney Disease. Treatment of Iron Deficiency Anemia. Assessment of IV Iron in Patients With Non-Dialysis-Dependent CKD. DOPPS Study. Ferric Pyrophosphate. Phosphate Binders. 2017 . Annual Data Report. Volume 1: Chronic Kidney Disease. 2. vol 1 Figure 7.1 Sources of prescription drug coverage in Medicare enrollees, by population, 201. 5. Data source: Medicare 5% sample. Point prevalent Medicare enrollees alive on January 1, 2015. Abbreviations: CKD, chronic kidney disease; LIS, Medicare Low-income Subsidy; Part D, Medicare prescription drug coverage benefit.. Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, 1999-2004 & 2007–2012 participants aged 20 & older. Whisker lines indicate 95% confidence intervals. Abbreviations: CKD, chronic kidney disease. This graphic also appears as Figure 1.2. Case 201-cv-00779-WBS -CKD Document 142 Filed 04/29/05 Page 2 of 2123456789-1- RD 1234567892 R Lowell Dilworth-Chemical Pathologist. CKD. CKD and Bone disease. Mineral . metabolism controlled by kidneys. , intestine, parathyroid glands and . bone. The . kidney plays a critical role in mineral homeostasis regulation and, therefore, renal disease exerts widespread effects on the skeleton and soft . Vol. 1, CKD, . Ch. . 6. 2. Data source: Medicare 5 percent sample. Abbreviations: CKD, chronic kidney disease; CHF, congestive heart failure, DM, diabetes mellitus.. v. ol 1 Table . 6.1 Point prevalent distribution of Medicare fee-for-service patients aged 65+ and total annual costs of Medicare Parts A and B services, by DM, CHF, and/or CKD, 2012. Namita Singh, MD, FASN. Year 2021. DISCLOSURES. I have no financial relationships with commercial interests to disclose.. This presentation does not include discussion of off-label or investigational use. . Narender Goel et al.. Middletown Medical PC,. Montefiore Medical Center & Albert Einstein College of . Medicine, New York. 4th International Conference on Nephrology & Therapeutics. September . Konstantia. Ass. Prof. of Nephrology D.U.TH.. Reduced quality of life . van Haalen et al. BMC Nephrology 2020. Worse renal survival. Lamerato et al. BMC Nephrology 2022. Increase in morbidity and mortality. Crude prevalence of chronic kidney disease (CKD) among adults with hypertension was over three times as high as that among adults without hypertension (24.6% vs 7.3%, 2017–March 2020). The prevalence of CKD among those with hypertension has remained constant from 2001 through March 2020. Age-standardized trends were consistent with the crude trends.. By. Mostafa. . Abd_Elsalam,MD. MUH,MNDU. Definitions. K/DOQI, 2002. Chronic kidney disease . Epidemiology of chronic kidney disease. . U.S. Renal Data System (2013) USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease.
Download Document
Here is the link to download the presentation.
"2 Vol 1, CKD, Ch 1 vol"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents